Influenza and RSV make a modest contribution to invasive pneumococcal disease incidence in the UK

Journal of Infection

Volumn 66, Issue 6, 2013, Pages 512-520

  Nicoli, Emily J ^a   Trotter, Caroline L ^a   Turner, Katherine M E ^a   Colijn, Caroline ^b   Waight, Pauline ^c   Miller, Elizabeth ^c  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Influenza; Invasive pneumococcal disease; Respiratory syncytial virus; Seasonality

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; ENVIRONMENTAL TEMPERATURE; HUMAN; INCIDENCE; INFANT; INFLUENZA; INFLUENZA VIRUS; MAJOR CLINICAL STUDY; NONHUMAN; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; SEASONAL VARIATION; SUNLIGHT; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; ENGLAND; EPIDEMIOLOGICAL MONITORING; HUMANS; INCIDENCE; INFANT; INFLUENZA, HUMAN; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; REGRESSION ANALYSIS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; SEASONS; STATISTICS, NONPARAMETRIC; WALES;

EID: 84876869720     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2013.02.007     Document Type: Article

References (54)

1. McCullers J.A. Insights into the interaction between influenza virus and pneumococcus. Clinical Microbiology Reviews 2006, 19(3):571-582.
2. Lipsitch M., Viboud C. Influenza seasonality: lifting the fog. Proceedings of the National Academy of Sciences of the United States of America 2009, 106(10):3645-3646.
3. Altizer S., Dobson A., Hosseini P., Hudson P., Pascual M., Rohani P. Seasonality and the dynamics of infectious diseases. Ecology Letters 2006, 9(4):467-484.
4. Ampofo K., Bender J., Sheng X., Korgenski K., Daly J., Pavia A.T., et al. Seasonal invasive pneumococcal disease in children: role of preceding respiratory viral infection. Pediatrics 2008, 122(2):229-237.
5. Kim P.E., Musher D.M., Glezen W.P., Rodriguez-Barradas M.C., Nahm W.K., Wright C.E. Association of invasive pneumococcal disease with season, atmospheric conditions, air pollution, and the isolation of respiratory viruses. Clinical Infectious Diseases 1996, 22(1):100-106.
6. Dowell S.F., Whitney C.G., Wright C., Rose C.E., Schuchat A. Seasonal patterns of invasive pneumococcal disease. Emerging Infectious Diseases 2003, 9(5):573-579.
7. Lofgren E., Fefferman N.H., Naumov Y.N., Gorski J., Naumova E.N. Influenza seasonality: underlying causes and modeling theories. Journal of Virology 2007, 81(11):5429-5436.
8. Rubin J.L., McGarry L.J., Klugman K.P., Strutton D.R., Gilmore K.E., Weinstein M.C. Public health and economic impact of vaccination with 7-valent pneumococcal vaccine (PCV7) in the context of the annual influenza epidemic and a severe influenza pandemic. BMC Infectious Disease 2010, 10:14.
9. Simonsen L., Taylor R.J., Young-Xu Y., Haber M., May L., Klugman K.P. Impact of pneumococcal conjugate vaccination of infants on pneumonia and influenza hospitalization and mortality in all age groups in the United States. MBio 2011, 2(1):e00309-e00310.
10. Gilca R., De S.G., Skowronski D., Boivin G., Buckeridge D.L. The need for validation of statistical methods for estimating respiratory virus-attributable hospitalization. American Journal of Epidemiology 2009, 170(7):925-936.
11. Grabowska K., Hogberg L., Penttinen P., Svensson A., Ekdahl K. Occurrence of invasive pneumococcal disease and number of excess cases due to influenza. BMC Infectious Disease 2006, 6:58.
12. Jansen A.G., Sanders E.A., Van Der Ende A., van Loon A.M., Hoes A.W., Hak E. Invasive pneumococcal and meningococcal disease: association with influenza virus and respiratory syncytial virus activity?. Epidemiology and Infection 2008, 136(11):1448-1454.
13. Kyaw M.H., Clarke S., Jones I.G., Campbell H. Incidence of invasive pneumococcal disease in Scotland, 1988-99. Epidemiology and Infection 2002, 128(2):139-147.
14. Murdoch D.R., Jennings L.C. Association of respiratory virus activity and environmental factors with the incidence of invasive pneumococcal disease. Journal of Infection 2009, 58(1):37-46.
15. Talbot T.R., Poehling K.A., Hartert T.V., Arbogast P.G., Halasa N.B., Edwards K.M., et al. Seasonality of invasive pneumococcal disease: temporal relation to documented influenza and respiratory syncytial viral circulation. American Journal of Medicine 2005, 118(3):285-291.
16. Toschke A.M., Arenz S., von K.R., Puppe W., Weigl J.A., Hohle M., et al. No temporal association between influenza outbreaks and invasive pneumococcal infections. Archives of Disease in Childhood 2008, 93(3):218-220.
17. Walter N.D., Taylor T.H., Shay D.K., Thompson W.W., Brammer L., Dowell S.F., et al. Influenza circulation and the burden of invasive pneumococcal pneumonia during a non-pandemic period in the United States. Clinical Infectious Diseases 2010, 50(2):175-183.
18. Watson M., Gilmour R., Menzies R., Ferson M., McIntyre P. The association of respiratory viruses, temperature, and other climatic parameters with the incidence of invasive pneumococcal disease in Sydney, Australia. Clinical Infectious Diseases 2006, 42(2):211-215.
19. Kuster S.P., Tuite A.R., Kwong J.C., McGeer A., Fisman D.N. Evaluation of coseasonality of influenza and invasive pneumococcal disease: results from prospective surveillance. PLoS Medicine 2011, 8(6):e1001042. [Epub 2011/06/21].
20. HPA, Goddard N.L., Joseph C.A., Zambon M., Nunn M., Fleming D., et al. Influenza surveillance in the United Kingdom: October 2000 to May 2001. Communicable Disease Report CDR Weekly 2001, 11:1-7. [serial online].
21. Trotter C.L., Waight P., Andrews N.J., Slack M., Efstratiou A., George R., et al. Epidemiology of invasive pneumococcal disease in the pre-conjugate vaccine era: England and Wales, 1996-2006. Journal of Infection 2010, 60(3):200-208.
22. Laboratory Reporting to the Health Protection Agency Guide for diagnostic laboratories. Version 3.0 August 2010, Health Protection Agency, London, Available from:. http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1194947381307.
23. Parker D.E., Legg T.P., Folland C.K. A new daily central England temperature series, 1772-1991. International Journal of Climatology 1992, 12(4):317-342.
24. Mangtani P., Hajat S., Kovats S., Wilkinson P., Armstrong B. The association of respiratory syncytial virus infection and influenza with emergency admissions for respiratory disease in London: an analysis of routine surveillance data. Clinical Infectious Diseases 2006, 42(5):640-646.
25. Braga A.L., Zanobetti A., Schwartz J. The effect of weather on respiratory and cardiovascular deaths in 12 U.S. cities. Environmental Health Perspectives 2002, 110(9):859-863.
26. Fisman D. Seasonality of viral infections: mechanisms and unknowns. Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2012, 18(10):946-954. [Epub 2012/07/24].
27. Tang J.W., Lai F.Y., Nymadawa P., Deng Y.M., Ratnamohan M., Petric M., et al. Comparison of the incidence of influenza in relation to climate factors during 2000-2007 in five countries. Journal of Medical Virology 2010, 82(11):1958-1965. [Epub 2010/09/28].
28. du Prel J.B., Puppe W., Grondahl B., Knuf M., Weigl J.A., Schaaff F., et al. Are meteorological parameters associated with acute respiratory tract infections?. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2009, 49(6):861-868. [Epub 2009/08/12].
29. Lowen A.C., Steel J., Mubareka S., Palese P. High temperature (30 °C) blocks aerosol but not contact transmission of influenza virus. Journal of Virology 2008, 82(11):5650-5652. [Epub 2008/03/28].
30. Tang J.W. The effect of environmental parameters on the survival of airborne infectious agents. Journal of the Royal Society, Interface/the Royal Society 2009, 6(Suppl. 6):S737-S746. [Epub 2009/09/24].
31. Yusuf S., Piedimonte G., Auais A., Demmler G., Krishnan S., Van Caeseele P., et al. The relationship of meteorological conditions to the epidemic activity of respiratory syncytial virus. Epidemiology and Infection 2007, 135(7):1077-1090. [Epub 2007/03/10].
32. White A.N., Ng V., Spain C.V., Johnson C.C., Kinlin L.M., Fisman D.N. Let the sun shine in: effects of ultraviolet radiation on invasive pneumococcal disease risk in Philadelphia, Pennsylvania. BMC Infectious Diseases 2009, 9:196. [Epub 2009/12/08].
33. Paynter S., Weinstein P., Ware R.S., Lucero M.G., Tallo V., Nohynek H., et al. Sunshine, rainfall, humidity and child pneumonia in the tropics: time-series analyses. Epidemiology and Infection 2012, 1-9. [Epub 2012/08/14].
34. Dowell S.F. Seasonal variation in host susceptibility and cycles of certain infectious diseases. Emerging Infectious Diseases 2001, 7(3):369-374. [Epub 2001/06/01].
35. Cannell J.J., Vieth R., Umhau J.C., Holick M.F., Grant W.B., Madronich S., et al. Epidemic influenza and vitamin D. Epidemiology and Infection 2006, 134(6):1129-1140. [Epub 2006/09/09].
36. Hayes C.E., Nashold F.E., Spach K.M., Pedersen L.B. The immunological functions of the vitamin D endocrine system. Cellular and Molecular Biology 2003, 49(2):277-300. [Epub 2003/07/31].
37. Gay N.J., Andrews N.J., Trotter C.L., Edmunds W.J. Estimating deaths due to influenza and respiratory syncytial virus. JAMA: The Journal of the American Medical Association 2003, 289(19):2499. [author reply 500-2. Epub 2003/05/22].
38. Thompson W.W., Weintraub E., Dhankhar P., Cheng P.Y., Brammer L., Meltzer M.I., et al. Estimates of US influenza-associated deaths made using four different methods. Influenza Other Respi Viruses 2009, 3(1):37-49.
39. Bosch A.A., Biesbroek G., Trzcinski K., Sanders E.A., Bogaert D. Viral and bacterial interactions in the upper respiratory tract. PLoS Pathogens 2013, 9(1):e1003057. [Epub 2013/01/18].
40. Plotkowski M.C., Beck G., Puchelle E. A new model for studying bacterial adherence to the respiratory epithelium. Brazilian Journal of Medical and Biological Research = Revista brasileira de pesquisas medicas e biologicas/Sociedade Brasileira de Biofisica [et al] 1988, 21(2):285-288. [Epub 1988/01/01].
41. Feldman C., Read R., Rutman A., Jeffery P.K., Brain A., Lund V., et al. The interaction of Streptococcus pneumoniae with intact human respiratory mucosa in vitro. The European Respiratory Journal: Official Journal of the European Society for Clinical Respiratory Physiology 1992, 5(5):576-583. [Epub 1992/05/01].
42. Pittet L.A., Hall-Stoodley L., Rutkowski M.R., Harmsen A.G. Influenza virus infection decreases tracheal mucociliary velocity and clearance of Streptococcus pneumoniae. American Journal of Respiratory Cell and Molecular Biology 2010, 42(4):450-460. [Epub 2009/06/13].
43. van der Flier M., Chhun N., Wizemann T.M., Min J., McCarthy J.B., Tuomanen E.I. Adherence of Streptococcus pneumoniae to immobilized fibronectin. Infection and Immunity 1995, 63(11):4317-4322. [Epub 1995/11/01].
44. Plotkowski M.C., Puchelle E., Beck G., Jacquot J., Hannoun C. Adherence of type I Streptococcus pneumoniae to tracheal epithelium of mice infected with influenza A/PR8 virus. The American Review of Respiratory Disease 1986, 134(5):1040-1044. [Epub 1986/11/01].
45. Peltola V.T., McCullers J.A. Respiratory viruses predisposing to bacterial infections: role of neuraminidase. Pediatric Infectious Disease Journal 2004, 23(1 Suppl.):S87-S97.
46. Hament J.M., Aerts P.C., Fleer A., Van Dijk H., Harmsen T., Kimpen J.L., et al. Enhanced adherence of Streptococcus pneumoniae to human epithelial cells infected with respiratory syncytial virus. Pediatric Research 2004, 55(6):972-978. [Epub 2004/04/23].
47. McGillivary G., Mason K.M., Jurcisek J.A., Peeples M.E., Bakaletz L.O. Respiratory syncytial virus-induced dysregulation of expression of a mucosal beta-defensin augments colonization of the upper airway by non-typeable Haemophilus influenzae. Cellular Microbiology 2009, 11(9):1399-1408. [Epub 2009/06/09].
48. Cundell D.R., Gerard N.P., Gerard C., Idanpaan-Heikkila I., Tuomanen E.I. Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature 1995, 377(6548):435-438. [Epub 1995/10/05].
49. Avadhanula V., Rodriguez C.A., Devincenzo J.P., Wang Y., Webby R.J., Ulett G.C., et al. Respiratory viruses augment the adhesion of bacterial pathogens to respiratory epithelium in a viral species- and cell type-dependent manner. Journal of Virology 2006, 80(4):1629-1636. [Epub 2006/01/28].
50. Shahangian A., Chow E.K., Tian X., Kang J.R., Ghaffari A., Liu S.Y., et al. Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. The Journal of Clinical Investigation 2009, 119(7):1910-1920. [Epub 2009/06/03].
51. McNamee L.A., Harmsen A.G. Both influenza-induced neutrophil dysfunction and neutrophil-independent mechanisms contribute to increased susceptibility to a secondary Streptococcus pneumoniae infection. Infection and Immunity 2006, 74(12):6707-6721. [Epub 2006/09/20].
52. Zakikhany K., Degail M.A., Lamagni T., Waight P., Guy R., Zhao H., et al. Increase in invasive Streptococcus pyogenes and Streptococcus pneumoniae infections in England, December 2010 to January 2011. Euro Surveillance 2011, 16(5).
53. O'Brien K.L., Walters M.I., Sellman J., Quinlisk P., Regnery H., Schwartz B., et al. Severe pneumococcal pneumonia in previously healthy children: the role of preceding influenza infection. Clinical Infectious Diseases 2000, 30(5):784-789.
54. Chien Y.W., Levin B.R., Klugman K.P. The anticipated severity of a " 1918-like" influenza pandemic in contemporary populations: the contribution of antibacterial interventions. PLoS One 2012, 7(1):e29219. [Epub 2012/02/01].